rss
J Am Med Inform Assoc 18:32-37 doi:10.1136/jamia.2010.007609
  • Research and applications

Ability of pharmacy clinical decision-support software to alert users about clinically important drug–drug interactions

  1. Daniel C Malone1,2
  1. 1Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, Arizona, USA
  2. 2Center for Health Outcomes and PharmacoEconomic Research (HOPE), The University of Arizona College of Pharmacy, Tucson, Arizona, USA
  3. 3The University of Arizona College of Pharmacy, Tucson, Arizona, USA
  1. Correspondence to Dr Daniel C Malone, University of Arizona, PO Box 210202, 1295N Martin, Drachman Hall B307F, Tucson, AZ 85721-0202, USA; malone{at}pharmacy.arizona.edu
  • Received 26 July 2010
  • Accepted 3 November 2010
  • Published Online First 3 December 2010

Abstract

Objective Pharmacy clinical decision-support (CDS) software that contains drug–drug interaction (DDI) information may augment pharmacists' ability to detect clinically significant interactions. However, studies indicate these systems may miss some important interactions. The purpose of this study was to assess the performance of pharmacy CDS programs to detect clinically important DDIs.

Design Researchers made on-site visits to 64 participating Arizona pharmacies between December 2008 and November 2009 to analyze the ability of pharmacy information systems and associated CDS to detect DDIs. Software evaluation was conducted to determine whether DDI alerts arose from prescription orders entered into the pharmacy computer systems for a standardized fictitious patient. The fictitious patient's orders consisted of 18 different medications including 19 drug pairs—13 of which were clinically significant DDIs, and six were non-interacting drug pairs.

Measurements The sensitivity, specificity, positive predictive value, negative predictive value, and percentage of correct responses were measured for each of the pharmacy CDS systems.

Results Only 18 (28%) of the 64 pharmacies correctly identified eligible interactions and non-interactions. The median percentage of correct DDI responses was 89% (range 47–100%) for participating pharmacies. The median sensitivity to detect well-established interactions was 0.85 (range 0.23–1.0); median specificity was 1.0 (range 0.83–1.0); median positive predictive value was 1.0 (range 0.88–1.0); and median negative predictive value was 0.75 (range 0.38–1.0).

Conclusions These study results indicate that many pharmacy clinical decision-support systems perform less than optimally with respect to identifying well-known, clinically relevant interactions. Comprehensive system improvements regarding the manner in which pharmacy information systems identify potential DDIs are warranted.

Footnotes

  • This study was presented as a poster at the American Medical Informatics Association AMIA Now! 2010 Conference, Phoenix, AZ, May 25–27, 2010.

  • Agency for Healthcare Research and Quality 5 U18 HS017001-02

  • Funding This study was funded by the Agency for Healthcare Research and Quality (# 5 U18 HS017001-02).

  • Ethics approval This study was conducted with the approval of the University of Arizona.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Access policy for JAMIA

All content published in JAMIA is deposited with PubMed Central by the publisher with a 12 month embargo. Authors/funders may pay an Unlocked fee of $2,000 to make the article free on the JAMIA website and PMC immediately on publication.

All content older than 12 months is freely available on this website.

AMIA members can log in with their JAMIA user name (email address) and password or via the AMIA website.